BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Sheng L, Liu L, Hu Y, Chen Y, Lou L. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis. BMC Gastroenterol 2020;20:98. [PMID: 32272891 DOI: 10.1186/s12876-020-01222-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Masana L, Correig E, Rodríguez-Borjabad C, Anoro E, Arroyo JA, Jericó C, Pedragosa A, Miret M, Näf S, Pardo A, Perea V, Pérez-Bernalte R, Plana N, Ramírez-Montesinos R, Royuela M, Soler C, Urquizu-Padilla M, Zamora A, Pedro-Botet J, Group OBOTSR. EFFECT oF STATIN THERAPY oN SARS-CoV-2 INFECTION-RELATED. Eur Heart J Cardiovasc Pharmacother 2020:pvaa128. [PMID: 33135047 DOI: 10.1093/ehjcvp/pvaa128] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
2 Orabi D, Berger NA, Brown JM. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. Cancers (Basel) 2021;13:3473. [PMID: 34298687 DOI: 10.3390/cancers13143473] [Reference Citation Analysis]
3 Goh MJ, Sinn DH, Woo SY, Kim S. REPLY. Hepatology 2021;73:1622-3. [PMID: 32961603 DOI: 10.1002/hep.31567] [Reference Citation Analysis]
4 Wang Y, Wang W, Wang M, Shi J, Jia X, Dang S, Granito A. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-15. [DOI: 10.1155/2022/5389044] [Reference Citation Analysis]
5 Sung S, Al-Karaghouli M, Kalainy S, Cabrera Garcia L, Abraldes JG. A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis. BMC Gastroenterol 2021;21:120. [PMID: 33726685 DOI: 10.1186/s12876-021-01704-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moctezuma-Velazquez C, Abraldes JG. Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered. Am J Gastroenterol 2021;116:2197-8. [PMID: 34279010 DOI: 10.14309/ajg.0000000000001385] [Reference Citation Analysis]
7 Yeh JJ, Lai JN, Lin CL, Hsu CY, Kao CH. Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort. BMJ Open 2021;11:e047039. [PMID: 34635513 DOI: 10.1136/bmjopen-2020-047039] [Reference Citation Analysis]
8 Francis P, Forman LM. Statins Show Promise Against Progression of Liver Disease. Clin Liver Dis (Hoboken) 2021;18:280-7. [PMID: 34976372 DOI: 10.1002/cld.1143] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wong YJ, Qiu TY, Ng GK, Zheng Q, Teo EK. Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis. J Clin Gastroenterol 2021;55:615-23. [PMID: 33606427 DOI: 10.1097/MCG.0000000000001478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]